Enhancer of zeste homolog 2 (EZH2), a tri-methylase for histone H3 lysine 27 to turn the chromosomes into a translation-inhibitory state, is bound by exosomal miR-101 to bring fulvestrant resistance to sensitive BC cells [131,135]. Here, EZH2 is linked to breast cancer.